Teladoc Health (NYSE:TDOC) Shares Gap Down – Here’s What Happened

Teladoc Health, Inc. (NYSE:TDOC) gapped down prior to trading on Friday . The stock had previously closed at $9.39, but opened at $9.11. Teladoc Health shares last traded at $9.35, with a volume of 410,283 shares changing hands.

Analyst Ratings Changes

TDOC has been the topic of several research analyst reports. The Goldman Sachs Group dropped their target price on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Royal Bank of Canada raised their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Oppenheimer decreased their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Finally, Bank of America lifted their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $11.26.

Teladoc Health Stock Down 2.5 %

The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of -1.59 and a beta of 1.27. The business’s fifty day moving average is $10.62 and its two-hundred day moving average is $9.65.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Equities analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Brucke Financial Inc. purchased a new stake in shares of Teladoc Health during the 4th quarter worth approximately $92,000. Vise Technologies Inc. raised its position in Teladoc Health by 4.9% in the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock valued at $274,000 after purchasing an additional 1,405 shares during the last quarter. PharVision Advisers LLC purchased a new stake in Teladoc Health in the 4th quarter valued at $301,000. Twinbeech Capital LP raised its position in Teladoc Health by 63.8% in the 4th quarter. Twinbeech Capital LP now owns 382,735 shares of the health services provider’s stock valued at $3,479,000 after purchasing an additional 149,118 shares during the last quarter. Finally, Two Sigma Advisers LP raised its position in Teladoc Health by 213.0% in the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock valued at $20,532,000 after purchasing an additional 1,537,094 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.